Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
118 Cards in this Set
- Front
- Back
- 3rd side (hint)
Disease |
Change in state of health |
|
|
Symptoms |
Changes in body function Not visible to observer (Pain, malaise) |
|
|
Signs |
Visible changes in body function See the sign! (Fever, bleeding) |
|
|
Epidemiology |
Study of disease: Patterns of disease Statistics Agents, Spread, SnS, Prevention & Treatment, In a population |
|
|
Etiology |
Causal agents Cause of disease |
|
|
Pathogen |
Any disease causing agent |
|
|
Contamination |
Incoming microbes on host surface |
|
|
Infection |
Invasion of tissues |
|
|
Etiological agent |
Specific name of the pathogen |
|
|
Symbiosis |
Living together |
|
|
Mutualism |
Mutually beneficial ++ |
|
|
Commensalism |
One benefits, no affect on other +0 |
|
|
Commensalism |
One benefits, no affect on other +0 |
|
|
Parasitism |
1 benefits at cost to other +- |
|
|
Opportunist |
Normally harmless Does not cause disease, under normal conditions |
|
|
Microbial antagonist |
Battle it out |
|
|
Benefits of resident microbiota |
Stimulate: immune and other systems Defense: create environment unfavorable to pathogens Prevent: overgrowth of opportunists Required: normal intestinal development Produce: micronutrients (Vit K & B) |
|
|
Adverse effects of resident microbiota |
Endogenous infection: opportunists multiply, disrupt tissue Reservoirs Carriers |
|
|
Microbiota cell amount |
1 x 10^14 (1 × 10^13 body cells) |
|
|
G.I tract is |
25-35 feet long Anaerobic |
|
|
Vaginal tract microflora |
pH 3.5- 4.5 Anaerobic Beneficial flora Lactobacilli E. coli from gut is bad here |
|
|
Where flora comes from |
In utero: microbe-free Lactobacilli: multiply in vag. tract before birth (prominent, produce H2O2) Different flora: vag. Birth vs C-section, breast vs bottle Environment Flora stabilizes |
|
|
Where flora comes from |
In utero: microbe-free Lactobacilli: multiply in vag. tract before birth (prominent, produce H2O2) Different flora: vag. Birth vs C-section, breast vs bottle Environment Flora stabilizes |
|
|
Where flora comes from |
In utero: microbe-free Lactobacilli: multiply in vag. tract before birth (prominent, produce H2O2) Different flora: vag. Birth vs C-section, breast vs bottle Environment Flora stabilizes |
|
|
Koch's postulates |
Presence of pathogen Isolation Inoculate Disease Isolate original organism |
|
|
Why can't Koch' s postulates be used for every etiological agent/pathogen? |
Unethical Many microbes cause same disease/SnS |
|
|
Frequency |
Endemic Epidemic Pandemic Sporadic |
|
|
Frequency |
Endemic Epidemic Pandemic Sporadic |
|
|
Endemic |
Constantly present |
|
|
Epidemic |
Sudden, Higher than normal incidence |
|
|
Pandemic |
Spreads worldwide |
|
|
Sporadic |
Appears randomly, unpredictably |
|
|
Disease cycle |
Survival outside host (reservoir) Transmission to host Portal of Entry ---------------------------------------- Attachment to target tissue Colonization Host damage Portal of exit |
|
|
When does disease start during disease cycle? |
Attachment |
|
|
Reservoir |
Primary habitat Where pathogen originates |
|
|
Reservoir |
Primary habitat Where pathogen originates |
|
|
Endogenous infection |
Caused by hosts own opportunists |
|
|
Endogenous infection |
Caused by hosts own opportunists |
|
|
Exogenous infections |
Enter host from environment |
|
|
Exogenous infections |
Enter host from environment |
|
|
Human reservoirs |
Asymptomatic: seem healthy Symptomatic |
|
|
Zoonoses |
Diseases transmitted from animals to humans (Directly or indirectly) Both source & spread/transmission |
|
|
Animal reservoirs |
150+ pathogens infect both animals and humans |
|
|
Nonliving reservoirs |
Inert environment Soil Water Food |
|
|
Soil |
Clostridium tetani C. Botulinum Fungi (ringworm) |
|
|
Water |
Vibrio cholerae Salmonella typhi Giardia |
|
|
Food |
Staphylococcus toxins Salmonella |
|
|
Nosocomial infections |
Disease acquired during hospital/health facility stay 10% of admitted patients acquire infection UTIs 40% Surgical wounds 19% Respiratory 15% |
|
|
Universal precautions |
Guidelines established by CDC to reduce risks of disease transmission in health care settings |
|
|
Communicable diseases |
Can spread from living to living hosts Directly or indirectly Not all are communicable, but transmission can still occur |
|
|
Non-communicable disease |
Picked up from environment but not passed to another living host. |
|
|
Contact transmission |
Direct Indirect Direct Droplet |
|
|
Direct contact transmission |
Body contact w/in a meter Nothing between Horizontal/vertical transmission |
|
|
Indirect transmission |
Requires fomite (Involves object) Nonliving to living |
|
|
Direct Droplet transmission |
Cough Sneeze Dried mucous Travels less than 1 meter |
|
|
Transmission groups |
Contact Vehicle Vector |
|
|
Vehicle transmission |
Non-living carrier to living Over 1 meter (Indirect host-host transmission) Water: oral-fecal Air: long-distance droplets Food: hamburgers |
|
|
Vector transmission |
Living organisms transmit disease from one host to another |
|
|
Vector transmission |
Living organisms transmit disease from one host to another |
|
|
Mechanical vectors |
On insect body Picked up on surface Surface carried |
|
|
Biological vectors |
Internally carried |
|
|
Control of transmission |
Isolation Quarantine Immunization Vector control |
|
|
Isolation |
Patient has communicable disease |
|
|
Quarantine |
Separates "healthy" person exposed to communicable disease |
|
|
Vector control |
Pesticide Insecticide Mosquito net Clean up food No swimming dogs: Leptospira spirochetes |
|
|
Portals of entry |
Skin Resp. & dig. tracts Genitals, urinary tracts Mucous membranes Placental + more |
|
|
Pathogenicity |
Ability to cause disease in host (Easy to catch, fewer cells needed) |
|
|
Virulence |
Degree of severity How evil? Death? |
|
|
Portal of entry applies to |
Pathogenicity |
|
|
Penetration/adhesion applies to |
Pathogenicity |
|
|
Evasion of host defences applies to |
Pathogenicity Virulence |
|
|
Damage to host cells applies to |
Virulency |
Cytopathic effects |
|
Portal of exit applies to |
Pathogenicity |
|
|
Infectious dose |
# of cells needed to cause 50% of healthy hosts to become infected (Pathogenicity) |
|
|
Lethal dose |
# of cells or toxin potency to kill 50% of inoculated hosts (Virulence) |
|
|
Factors affecting disease process |
Numbers of microbes Attachment Phagocytosis avoidance Extracellular enzymes Exotoxins Endotoxins |
|
|
Avoidance of phagocytosis |
Capsule- slippery Special proteins Wax Leukociden- destroys neutrophils & macrophages |
|
|
Production of extracellular enzymes |
Digestion, destruction of tissues: Collagenase Keratinase Hyaluronidase Streptokinase (dissolves clot) Coagulase Mucinase Hemolysin |
|
|
Species-specific Exotoxins |
Diptheria- inhibits protein synth. Erythrotoxin- from Streptococcus pyogenes Vibrio Enterotoxin- (cholera) affects G.I cells Botulinum & Tetanus neurotoxins- nerves |
|
|
Attachment (how) |
Fimbrae- fringe Glycocalyx- sticky, sugary crown Adhesin- ligands, bind to host receptors (glue) Biofilms- living cells bind together and adhere to a surface |
|
|
Evasion of host defences (immune system) |
Antigenic variation Pathogen keeps changing Many variants may be present in one host |
|
|
Exotoxin production |
Proteins produced inside Especially gram + Species-specific Heat-labile |
|
|
Antitoxins |
Antibodies Produced by WBCs Combat exotoxins |
|
|
Toxoids |
Altered exotoxins Induce immunity Injected |
|
|
Endotoxin production |
Lipids in Gram - cell wall Released by dead pathogens Effects: fever, aching, weakness, TSS |
|
|
Gram + pathogens |
Some produce exotoxins Protein by-products No fever Neutralized by antitoxin Small lethal dose
|
|
|
Gram + pathogens |
Some produce exotoxins Protein by-products No fever Neutralized by antitoxin Small lethal dose
|
|
|
Gram - pathogens |
Endotoxins in LPS Lipid Fever Not neutralized by antitoxin Relatively large lethal dose |
|
|
Portals of Exit |
How infectious agents exit host So they can enter new host Body fluids Feces |
|
|
Portals of Exit |
How infectious agents exit host So they can enter new host Body fluids Feces |
|
|
Disease stages |
IPIDC: Incubation Prodromal Illness Decline Convalescence
|
|
|
Incubation |
Variable 2-3 days, most diseases No SnS |
|
|
Prodromal stage |
Mild SnS Malaise Variable |
|
|
Illness stage |
Max SnS Immune system activated If fails= patient death |
|
|
Decline stage |
SnS decrease Fever departs Vulnerable to 2° infection |
|
|
Convalescence stage |
Body repairs Returning to normal |
|
|
Localized |
Still where it got in at |
|
|
Systemic |
System-wide |
|
|
Focal |
Went somewhere specific |
|
|
Acute |
Quick Short |
|
|
Chronic |
Long time to develop or go away |
|
|
-itis |
Inflammation Swollen, heated, painful |
|
|
-emia |
Blood |
|
|
-osis/iasis |
Disease from pathogen (Tuberculosis) |
|
|
-oma |
Tumor Cancer |
|
|
Disease frequency |
Incidence Prevalence Morbidity Mortality |
|
|
Incidence |
Number of new cases |
|
|
Prevalence |
Number of infected people Any given time |
|
|
Morbidity |
Number of disease cases In a specific time period With respect to the population |
|
|
Mortality rate |
Number of disease deaths during specific with respect to total population. (Deaths per 100,000 people per year) |
|
|
Mortality rate |
Number of disease deaths during specific with respect to total population. (Deaths per 100,000 people per year) |
|
|
Mortality rate |
Number of disease deaths during specific with respect to total population. (Deaths per 100,000 people per year) |
|
|
Notifiable |
Agencies required by law to collect data |
|
|
Contagious |
Easy host to host transmission |
|
|
Communicable |
Host to host transmission |
|
|
Non-communicable |
Not host to host transmission |
|
|
Correlation |
One factor assumed to be related to another |
|
|
Cause and effect |
One factor is proven to cause measurable change in another |
|